Author: Justine Chabot

Post

FHC Partners with Neurotargeting to Offer New Solution for Epilepsy Treatment

BOWDOIN, ME – FHC, Inc. and Neurotargeting, LLC have released WayPoint™ Navigator 4.5 planning software, now allowing epileptologists, neurosurgeons, and…

Post

FHC Announces Comprehensive Epilepsy Solutions for Neurosurgery

BOWDOIN, ME – According to the American Epilepsy Society, at least 30-40% of individuals don’t respond to current antiepileptic drugs,…

Post

FHC Awarded 2019 People’s Bank Award

Last night, FHC was awarded the 2019 People’s United Bank Innovation and Technology Award at the 20th annual Maine Family…

Post

Haer named FHC’s Chairman of the Board

FHC, Inc., a global manufacturer of products for the neuroscience industry, is pleased to announce that F. Andrew (Andy) Haer…

Post

FHC Announces FDA Clearance for Guideline 5 System

BOWDOIN, ME – January 8, 2019 – FHC, Inc., announced today that is has received 510(k) clearance from the Food…

Post

FHC products enable use of new surgical technique for Parkinson’s sufferers in Australia

Australia’s 9News recently featured a story about a new surgical approach, using FHC products, that is treating Australian patients affected…

Post

FHC Partners to Promote Brain Awareness Week 2019

Brain Awareness Week (BAW) 2019 is being celebrated March 11th-17th.  This year, FHC has become a BAW partner, joining other…

Post

FHC Partners with the University of Kentucky to Explore New Parkinson’s Treatment

FHC’s Innovation Center recently collaborated with Dr. Craig Van Horne at the University of Kentucky to explore a new treatment…

Popup Image